The current approval is first of the many fillings made by the company's CDMO partners from the flagship facility in Bangalore
CINRYZE is plasma-derived C1-I NH approved for routine prevention (prophylaxis), short-term prevention or pre-procedure prevention, and acute attacks of HAE.
Spiro will be responsible for the overall strategy, implementation and growth of Lupin’s U.S. Generics business
This is the second line opened this year for parenteral drug product clinical and commercial manufacturing, with an annual capacity of 10 million units
Gland Pharma enters into a Put Option Agreement to acquire 100% of Cenexi Group
The drug will be manufactured at the group's injectable manufacturing facility at Jarod, near Vadodara, India
Famotidine Injection is indicated to treat ulcers of the stomach and intestines and to prevent intestinal ulcers from coming back after they have healed
Ketorolac Tromethamine is advised for the short-term management of moderately severe acute pain in adult patients
This is the first injectable product approval from our General Sterile Facility (F-3) which was inspected in August, 2022.
The company is committed to addressing the observations at the earliest, and gaining approval for injectable manufacturing for the US
Subscribe To Our Newsletter & Stay Updated
